July 01, 2026

The Benefits of Intravitreal Steroids During Vitrectomy

Triamcinolone acetonide enhances vitreous visualization, facilitates surgical maneuvers, and provides postoperative anti-inflammatory effects.

Retinal Physician

July 01, 2026

Clinical Trial Update July/August 2026

Access Retinal Physician's listing of all active clinical trials in AMD, DME, RVO, and uveitis.

Retinal Physician

July 01, 2026

Approaching Uveitic Retinal Detachments

Uveitis Corner: Careful control of inflammation, thoughtful surgical planning, and vigilant postoperative management can help optimize outcomes in these complex cases.

Retinal Physician

July 01, 2026

Emphasis on Vitreoretinal Surgery

Upfront: Monthly reflection by Editor in Chief Diana V. Do, MD.

Retinal Physician

June 17, 2026

New Drugs, New Delivery Systems: The New Landscape of Ophthalmic Therapeutics

Mitch Ibach, OD, FAAO, and Jake Lang, OD, FAAO, review what optometrists need to know about mechanism-based treatment in dry eye, glaucoma, presbyopia, and immune-mediated and inflammatory eye disease.

Optometric Management

June 17, 2026

Herpetic Eye Disease Is Not a Single Event

Joseph P. Shovlin, OD, FAAO, reviewed diagnosis, management, and emerging evidence related to chronic herpetic eye disease prevention at Optometry's Meeting 2026.

Optometric Management

May 21, 2026

New Target for Uveitis Therapy

Could targeting cGAS-STING represent a new treatment avenue for uveitis?

The Ophthalmologist

May 15, 2026

Smoking Doubles Risk of Vision Loss

New research indicates smoking doubles the risk of multiple sight-threatening conditions

The Ophthalmologist

May 07, 2026

Vamikibart Shows Early Safety in Uveitic Macular Edema

Phase 1 nonrandomized trial reported no drug-related serious adverse events, but efficacy remains unproven

Conexiant

May 04, 2026

The Art of Ophthalmology 2026

Showcasing artwork and images from across the spectrum of ophthalmology

The Ophthalmologist